Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002029528 | SCV002306010 | uncertain significance | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2021-09-30 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with cysteine at codon 234 of the MCCC2 protein (p.Arg234Cys). The arginine residue is moderately conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs549784997, ExAC 0.03%). This variant has not been reported in the literature in individuals with MCCC2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV002029528 | SCV003810815 | uncertain significance | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2021-02-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003269100 | SCV003946968 | uncertain significance | Inborn genetic diseases | 2023-04-06 | criteria provided, single submitter | clinical testing | The c.700C>T (p.R234C) alteration is located in exon 7 (coding exon 7) of the MCCC2 gene. This alteration results from a C to T substitution at nucleotide position 700, causing the arginine (R) at amino acid position 234 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004752127 | SCV005363537 | uncertain significance | MCCC2-related disorder | 2024-03-20 | no assertion criteria provided | clinical testing | The MCCC2 c.700C>T variant is predicted to result in the amino acid substitution p.Arg234Cys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.015% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |